Cargando…

Testicular germ cell tumours’ clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival—a systematic review

PURPOSE: Testicular germ cell tumours (GCTs) represent the most common malignancy in young adult males with two thirds of all cases presenting with clinical stage I (CSI). Active surveillance is the management modality mostly favoured by current guidelines. This systematic review assesses the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruf, Christian G., Schmidt, Stefanie, Kliesch, Sabine, Oing, Christoph, Pfister, David, Busch, Jonas, Heinzelbecker, Julia, Winter, Christian, Zengerling, Friedemann, Albers, Peter, Oechsle, Karin, Krege, Susanne, Lackner, Julia, Dieckmann, Klaus-Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Topic Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712330/ https://www.ncbi.nlm.nih.gov/pubmed/36107211 http://dx.doi.org/10.1007/s00345-022-04145-6

Ejemplares similares

First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment: A comprehensive review compiled by the German Testicular Cancer Study Group
por: Pfister, David, et al.
Publicado: (2022)

How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence
por: Winter, Christian, et al.
Publicado: (2022)

Can magnetic resonance imaging replace conventional computerized tomography for follow-up of patients with testicular cancer? A systematic review
por: Busch, Jonas, et al.
Publicado: (2022)

Prognostic factors in patients with clinical stage I nonseminoma—beyond lymphovascular invasion: a systematic review
por: Zengerling, Friedemann, et al.
Publicado: (2022)

Therapy of clinical stage IIA and IIB seminoma: a systematic review
por: Heinzelbecker, Julia, et al.
Publicado: (2021)

Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging
por: Wakileh, Gamal Anton, et al.
Publicado: (2021)

Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2021)

Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG)
por: Seidel, Christoph, et al.
Publicado: (2022)

Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer
por: Brandt, Maximilian Peter, et al.
Publicado: (2021)

German second-opinion network for testicular cancer: Sealing the leaky pipe between evidence and clinical practice
por: ZENGERLING, FRIEDEMANN, et al.
Publicado: (2014)

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2019)

Late relapsing germ cell tumors with elevated tumor markers
por: Che, Yue, et al.
Publicado: (2021)

Testicular germ cell tumors
por: Albers, Peter
Publicado: (2021)

Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative Review
por: Kaufmann, Ernest, et al.
Publicado: (2022)

No evidence for seasonal variations of the incidence of testicular germ cell tumours in Germany
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2023)

Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry
por: Fichtner, A., et al.
Publicado: (2022)

Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment
por: Majewski, Matthäus, et al.
Publicado: (2023)

Indications, feasibility and outcome of robotic retroperitoneal lymph node dissection for metastatic testicular germ cell tumours
por: Ohlmann, Carsten-Henning, et al.
Publicado: (2021)

Testicular seminoma clinical stage 1: treatment outcome on a routine care level
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2016)

Familial Testicular Germ Cell Tumor in Two Brothers With Emery Dreifuss Muscular Dystrophy Caused by an FHL-1 Mutation: A Case Report
por: Angerer, Markus, et al.
Publicado: (2023)

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2022)

Subsets of preoperative sex hormones in testicular germ cell cancer: a retrospective multicenter study
por: Törzsök, Péter, et al.
Publicado: (2023)

Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin
por: Belge, Gazanfer, et al.
Publicado: (2020)

Testicular prostheses in patients with testicular cancer - acceptance rate and patient satisfaction
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2015)

Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
por: Nitzsche, B, et al.
Publicado: (2012)

MicroRNA-371a-3p—The Novel Serum Biomarker in Testicular Germ Cell Tumors
por: Nestler, Tim, et al.
Publicado: (2023)

The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)
por: Seidel, Christoph, et al.
Publicado: (2021)

Sequential bilateral testicular tumours presenting with intervals of 20 years and more
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2013)

Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2020)

Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group
por: Classen, J, et al.
Publicado: (2003)

In Search of a Germ Theory Equivalent for Chronic Disease
por: Egger, Garry
Publicado: (2012)

Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses
por: Pratsinis, Manolis, et al.
Publicado: (2022)

Tertiary Syphilitic Gumma Mimicking Testicular Neoplasms
por: Angerer, Markus, et al.
Publicado: (2023)

5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells
por: Oing, Christoph, et al.
Publicado: (2018)

Imaging of testicular germ cell tumours
por: Dalal, P U, et al.
Publicado: (2006)

Multispecies Purification of Testicular Germ Cells
por: Lima, Ana C., et al.
Publicado: (2016)

Immunotherapy in Testicular Germ Cell Tumors
por: Kalavska, Katarina, et al.
Publicado: (2020)

GPER and Testicular Germ Cell Cancer
por: Chevalier, Nicolas, et al.
Publicado: (2021)

Treatment of germ cell testicular cancer
por: Koši Kunac, Ana, et al.
Publicado: (2020)

Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor
por: Belge, Gazanfer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7fc1mn2brtq6o88el9b719qvli